Study examines association between small-vessel disease, Alzheimer pathologyMay 12, 2014
Bottom Line: Cerebral small-vessel disease (SVD) and Alzheimer disease (AD) pathology appear to be associated.
Author: Maartje I. Kester, M.D., Ph.D., of the VU University Medical Center, Amsterdam, the Netherlands, and colleagues.
Background: AD is believed to be caused by the buildup of amyloid protein in the brain and tau tangles. Previous studies have suggested that SVD and vascular risk factors increase the risk of developing AD. In both SVD and vascular dementia (VaD), signs of AD pathology have been seen. But it remains unclear how the interaction between SVD and AD pathology leads to dementia.
How the Study Was Conducted: Authors examined the association between SVD and AD pathology by looking at magnetic resonance imaging (MRI)-based microbleeds (MB), white matter hyperintensities (WMH) and lacunes (which are measures for SVD) along with certain protein levels in cerebrospinal fluid (CSF) which reflect AD pathophysiology in patients with AD, VaD and healthy control patients. The authors also examined the relationship of apolipoprotein E (APOE) Ɛ4 genotype, a well-known risk factor for AD.
Results: The presence of both MBs and WMH was associated with lower CSF levels of Aβ42, suggesting a direct relationship between SVD and AD. Amyloid deposits also appear to be abnormal in patients with SVD, especially in (APOE) Ɛ4 carriers.
Discussion: "Our study supports the hypothesis that the pathways of SVD and AD pathology are interconnected. Small-vessel disease could provoke amyloid pathology while AD-associated cerebral amyloid pathology may lead to auxiliary vascular damage."
Editor's Note: The authors made conflict of interest and funding disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Media Advisory: To contact author Maartje I. Kester, M.D., Ph.D., email email@example.com
The JAMA Network Journals
Related Alzheimer Disease Articles:
In this paper, the researchers report on a straightforward expression and purification protocol to obtain [U-15N] and [U-2H,13C,15N] Aβ42.
Among adults who entered a study more than 25 years ago, an increasing number of midlife vascular risk factors, such as obesity, high blood pressure, diabetes, high cholesterol and smoking, were associated with elevated levels of brain amyloid (protein fragments linked to Alzheimer's disease) later in life, according to a study published by JAMA.
Researchers have uncovered a mechanism that helps block the accumulation of proteins involved in Alzheimer's disease.
Researchers at Ulsan National Institute of Science and Technology (UNIST) in South Korea have introduced a new approach to treat Alzheimer's disease.
A new study published by UAlberta researchers in the journal Alzheimer's and Dementia: Translational Research and Clinical Intervention examines if a compound called AC253 can inhibit a 'rogue' protein called amyloid.
Alzheimer's disease affects more than 35 million people, a number that is expected to increase in the coming years.
A study published today by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine describes that certain proteins playing a role in cancer progression and metastasis are stored as amyloid bodies in dormant cancer cells.
A research project has shown that an experimental model of Alzheimer's disease can be successfully treated with a commonly used anti-inflammatory drug.
While strokes are known to increase risk for dementia, much less is known about diseases of large and small blood vessels in the brain, separate from stroke, and how they relate to dementia.
Drugs used to treat diabetes could also be used to treat Alzheimer's disease, and vice versa, according to new research from the University of Aberdeen, published in Diabetologia (the journal of the European Association for the Study of Diabetes).
Related Alzheimer Disease Reading:
Alzheimer's Disease: What If There Was a Cure?: The Story of Ketones
by Mary T. Newport (Author)
In this second edition Dr. Newport, a neonatal practitioner, continues the story of Steve's progress and provides the most recent research on such topics as possible causes of Alzheimer's due to the herpes simplex virus and nitrosamine substances and how infection, inflammation and genetic makeup may affect an individual's response to fatty acid therapy. View Details
Alzheimer's Disease: What If There Was a Cure?
by Mary T. Newport (Author)
Though Dr. Mary T. Newport has provided professional care to newborns since 1983, she's led a double life since 2000 when she became a caregiver at home. That's when her beloved husband, Steve, first showed signs of Alzheimer's disease. After his deterioration accelerated in 2004, Dr. Newport began avidly researching ways to keep him functional for as long as possible. Since she understands medical terminology and scientific methods, she was thrilled to find new research showing that medium- chain fatty acids, which act like an alternative fuel in the insulin-deficient Alzheimer's brain,... View Details
Alzheimer's Disease: Prevention Strategies & Ways to Slow Progression
by Lisa Byrd (Author)
Nationally respected Gerontologist Lisa Bryd has brought together the latest preventative research, along with the newest techniques to slow age-related cognitive decline in a breakthrough book on the management of Alzheimer's. Filled with strategies, activities and approaches - cognitive interventions, exercise plans, diet solutions, ways to promote social engagement and medication treatments. Case studies and personal experiences highlight this must-have resource for anyone working with Alzheimer's, dementia and delirium patients. View Details
Mayo Clinic on Alzheimers Disease
by Ronald, C. Petersen (Author)
Your guide to understanding, treating, coping and caregiving. View Details
The 36-Hour Day: A Family Guide to Caring for People Who Have Alzheimer Disease, Related Dementias, and Memory Loss
by Nancy L. Mace (Author), Peter V. Rabins (Author)
The most trusted guide for caring for persons with Alzheimer's disease, memory loss, and dementia disorders-now revised and updated with practical and legal advice and compassionate guidance for families and caregivers.
When someone in your family suffers from Alzheimer's disease or other related memory loss diseases, both you and your loved one face immense challenges. For over thirty years, this book has been the trusted bible for families affected by dementia disorders. Now completely revised and updated, this guide features the latest information on the causes of dementia,... View Details
Alzheimer's Disease and Dementia: What Everyone Needs to Know®
by Steven R. Sabat (Author)
Alzheimer's is swiftly on the rise: it is estimated that every 67 seconds, someone develops the disease. For many, the words "Alzheimer's disease" or "dementia" immediately denote severe mental loss and, perhaps, madness. Indeed, the vast majority of media coverage of Alzheimer's disease (AD) and other types of dementia focuses primarily on the losses experienced by people diagnosed and the terrible burden felt by care partners yearning for a "magic bullet" drug cure.
Providing an accessible, question-and-answer-format primer on what touches so many lives, and yet so few of us... View Details
My Journey into Alzheimer's Disease
by Robert Davis (Author), Betty Davis (Author)
A book of encouragement of how one man of faith faced the oncoming darkness of Alzheimer's disease. In a powerful story of courage and faith, Davis shows how God gives strength and grace. View Details
by Dr. Paul Dash (Author), Dr. Nicole Villemarette-Pitman PhD (Author), Nicole Villemarette-Pittman (Author)
Alzheimer's Disease was a finalist for a 2005 ForeWord Book of the Year Award!
An estimated 5 million Americans suffer from Alzheimer's disease, only half of whom have been diagnosed. An uncertain but even larger number have mild cognitive impairment, often a precursor to Alzheimer's. By 2030, barring a cure for this illness, the number of individuals diagnosed with Alzheimer's disease is estimated to be 8 million, and by 2050, 14 million. The cost in both suffering and dollars on the part of patients and families is enormous and continues to grow worldwide.... View Details
A Pocket Guide to Understanding Alzheimer's Disease and Other Dementias, Second Edition
by James Warner (Author), Nori Graham (Author)
If you or a loved one are worried about Alzheimer's disease or other types of dementia, this pocket guide will help you to better understand the conditions, and how they are diagnosed and treated. Written by leading dementia experts, this book provides clear and concise information on:
· Diagnosis and treatments
· Getting help and support
· Tips for people living with dementia
· Advice for carers
This is a fully-updated edition of the popular Understanding Alzheimer's Disease and Other Dementias, which featured on the Reading Well Books on... View Details
Alzheimer's Disease: A Guide for Families and Caregivers
by Lenore Powell (Author), Katie Courtice (Author), Ed.D. Lenore Powell (Author), Katie Courtice (Author)
When people suffer from Alzheimer's disease, their family and friends usually must care for them and make decisions on their behalf, tasks that can be emotionally and physically draining. Backed by solid medical information about the specifics of the disease-from early signs, testing, and diagnosis to treatments and long-term care-this comprehensive guide will help family and caregivers alike be better prepared for the unique challenges ahead of them. An invaluable resource, Alzheimer's Disease explains how to cope with the many feelings provoked by the disease and provides practical care... View Details